The FRS2 family of docking/scaffolding adaptor proteins as therapeutic targets of cancer treatment

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.13, Iss.6, 2009-06, pp. : 689-700

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bcl-2 Family Proteins as Therapeutic Targets

Current Pharmaceutical Design, Vol. 16, Iss. 28, 2010-09 ,pp. : 3132-3148

Bentham Science Publishers

Access to resources Recommend Favorite

CARD Proteins as Therapeutic Targets in Cancer

Current Drug Targets, Vol. 5, Iss. 4, 2004-05 ,pp. : 367-374

Bentham Science Publishers

Access to resources Recommend Favorite

Exploration of Metastasis-related Proteins as Biomarkers and Therapeutic Targets in the Treatment of Head and Neck Cancer

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. : 613-622

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the BH3 Domain of Bcl-2 Family Proteins. A Brief History From Natural Products to Foldamers As Promising Cancer Therapeutic Avenues

Current Medicinal Chemistry, Vol. 20, Iss. 24, 2013-08 ,pp. : 2964-2978

Bentham Science Publishers

Access to resources Recommend Favorite

The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer

By Spears Melanie Bartlett John

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 6, 2009-06 ,pp. : 665-674

Informa Healthcare

Access to resources Recommend Favorite